Prevalence of Migraine and Other Types of Primary Headache in China: A Systematic Review and Meta-Analysis
Abstract
Abstract Introduction: Migraine and other types of primary headache are widely prevalent and are thought to have substantial economic implications on a global scale. Nevertheless, the precise prevalence rates in China exhibited discrepancies across various studies. The present study aimed to ascertain the prevalence of migraine and other primary headache disorders in China. Methods: A systematic search of peer-reviewed literature was conducted in the Chinese Wanfang, CNKI, PubMed, and MEDLINE databases from January 1988 to December 2023 to identify prevalence data on migraine and other primary headache disorders among the Chinese population, published in either English or Chinese language. The study utilized a random-effects model to summarize pooled prevalence estimates, with subgroup analyses conducted based on sex, age, publication year, and geographical region. Results: A total of 18 studies were included for detailed review and meta-analysis. The pooled prevalence of migraine and tension-type headache (TTH) in China was found to be 6.1% (95% CI: 4.1–8.6%) and 13.4% (95% CI: 7.2–21.2%), respectively. The prevalence of migraine in the years 1988–1999 was 1.3% (95% CI: 1.1–1.5%), while the prevalence of TTH was 5.0% (95% CI: 4.5–5.4%). In contrast, the prevalence of migraine in the years 2000–2023 increased to 7.0% (95% CI: 4.9–9.4%), with TTH prevalence at 13.2% (95% CI: 7.1–20.8%). The weighted-pooled prevalence of both migraine and TTH were higher in females than in…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 3,457,170 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.